NCT00531622 - An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder | Biotech Hunter

Enrollment

643

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Major Depressive Disorder

Interventions

DRUG

saredutant (SR48968)

oral administration, capsules

DRUG

escitalopram

oral administration, capsules

DRUG

placebo

oral administration, capsules

Trial Locations (6)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Bromma